Semaglutide is a key ingredient in Novo Nordisk’s popular weight-loss drug Wegovy and diabetes medication Ozempic, which has seen a dramatic increase in demand in recent years. Hims & Hers Health ...

The lawsuit claims the FDA's finding that there was no longer a shortage of the drugs' active ingredient semaglutide was ...